Lucy Day - 03 Jan 2025 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Signature
/s/ Lucy Day
Issuer symbol
ANTX
Transactions as of
03 Jan 2025
Net transactions value
-$3,965
Form type
4
Filing time
07 Jan 2025, 20:02:51 UTC
Previous filing
18 Mar 2024
Next filing
28 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Sale $3,965 -2,957 -8.3% $1.34 32,670 03 Jan 2025 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold pursuant to the terms of the grant to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units ("RSUs") on January 1, 2025.
F2 Includes 20,625 RSUs which vest as follows: 1/3rd of the RSUs vest annually over three years from January 1, 2025, subject to the Reporting Person continuing to provide services to the Company as an employee, consultant or director of the Company through each applicable vesting date.
F3 Includes 5,000 shares purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt from reporting under Section 16(b)3.